An approach to the development of interstitial lung disease in dermatomyositis: A study of 230 cases in China

Journal of International Medical Research

Volumn 41, Issue 2, 2013, Pages 493-501

  Wu, Hao ^a   Geng, Daoying ^a   Xu, Jinhua ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Dermatomyositis; Interstitial lung disease; Prognosis

Indexed keywords

CORTICOSTEROID; STEROID;

ADULT; AGED; ARTHRALGIA; ARTICLE; CHINA; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; COUGHING; DERMATOMYOSITIS; DISEASE ASSOCIATION; DYSPHAGIA; FEMALE; FOLLOW UP; HUMAN; INTERSTITIAL LUNG DISEASE; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; MYASTHENIA; RASH; RETROSPECTIVE STUDY; RISK FACTOR;

EID: 84878345708     PISSN: 03000605     EISSN: 14732300     Source Type: Journal    
DOI: 10.1177/0300060513476435     Document Type: Article

References (22)

1. Bohan A and Peter JB. Polymyositis and dermatomyositis (first of two parts). N Engl J Med 1975; 292: 344-347.
2. Bohan A and Peter JB. Polymyositis and dermatomyositis (second of two parts). N Engl J Med 1975; 292: 403-407.
3. Dalakas MC and Hohlfeld R. Polymyositis and dermatomyositis. Lancet 2003; 362: 971-982.
4. Schnabel A, Reuter M, Biederer J, et al. Interstitial lung disease in polymyositis and dermatomyositis: clinical course and response to treatment. Semin Arthritis Rheum 2003; 32: 273-284.
5. Ye S, Chen XX, Lu XY, et al. Adult clinically amyopathic dermatomyositis with rapid progressive interstitial lung disease: a retrospective cohort study. Clin Rheumatol 2007; 26: 1647-1654.
6. Kang EH, Lee EB, Shin KC, et al. Interstitial lung disease in patients with polymyositis, dermatomyositis and amyopathic dermatomyositis. Rheumatology (Oxford) 2005; 44: 1282-1286.
7. Kagen LJ. Amyopathic dermatomyositis. Arch Dermatol 1995; 131: 1458-1459.
8. Cotes JE, Chinn DJ, Quanjer PH, et al. Standardization of the measurement of transfer factor (diffusing capacity). Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official statement of the European Respiratory Society. Eur Respir J Suppl 1993; 16: 41-52.
9. Quanjer PH, Tammeling GJ, Cotes JE, et al. Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official statement of the European Respiratory Society. Eur Respir J Suppl 1993; 16: 5-40.
10. Müller NL and Miller RR. Computed tomography of chronic diffuse infiltrative lung disease. Part 1. Am Rev Respir Dis 1990; 142: 1206-1215.
11. Douglas WW, Tazelaar HD, Hartman TE, et al. Polymyositis-dermatomyositis-associated interstitial lung disease. Am J Respir Crit Care Med 2001; 164: 1182-1185.
12. Arakawa H, Yamada H, Kurihara Y, et al. Nonspecific interstitial pneumonia associated with polymyositis and dermatomyositis: serial high-resolution CT findings and functional correlation. Chest 2003; 123: 1096-1103.
13. Maugars YM, Berthelot JM, Abbas AA, et al. Long-term prognosis of 69 patients with dermatomyositis or polymyositis. Clin Exp Rheumatol 1996; 14: 263-274.
14. Sultan SM, Ioannou Y, Moss K, et al. Outcome in patients with idiopathic inflammatory myositis: morbidity and mortality. Rheumatology (Oxford) 2002; 41: 22-26.
15. Marie I, Hachulla E, Hatron PY, et al. Polymyositis and dermatomyositis: short term and long term outcome, and predictive factors of prognosis. J Rheumatol 2001; 28: 2230-2237.
16. Kim EA, Lee KS, Johkoh T, et al. Interstitial lung diseases associated with collagen vascular diseases: radiologic and histopathologic findings. Radiographics 2002; 22: S151-S165.
17. Fathi M, Dastmalchi M, Rasmussen E, et al. Interstitial lung disease, a common manifestation of newly diagnosed polymyositis and dermatomyositis. Ann Rheum Dis 2004; 63: 297-301.
18. Chen YJ, Wu CY and Shen JL. Predicting factors of interstitial lung disease in dermatomyositis and polymyositis. Acta Derm Venereol 2007; 87: 33-38.
19. Love LA, Leff RL, Fraser DD, et al. A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups. Medicine (Baltimore) 1991; 70: 360-374.
20. Wortmann RL. Idiopathic inflammatory diseases of muscle. In: Weisman ML, Weinblatt ME, Louie JS (eds) Treatment of the rheumatic diseases: Companion to Kelley's Textbook of rheumatology, 2nd ed. Philadelphia: WB Saunders, 2001, pp.390-402.
21. Latsi PI and Wells AU. Evaluation and management of alveolitis and interstitial lung disease in scleroderma. Curr Opin Rheumatol 2003; 15: 748-755.
22. Terriff BA, Kwan SY, Chan-Yeung MM, et al. Fibrosing alveolitis: chest radiography and CT as predictors of clinical and functional impairment at follow-up in 26 patients. Radiology 1992; 184: 445-449.